Marlborough

Advanced Cell Technology of Marlborough reported another quarterly loss as it continued testing for a vision-treatment drug and applied for federal approval of another drug that could potentially treat both humans and animals.

The U.S. Food and Drug Administration has approved a new drug made by Sunovion Pharmaceuticals to reduce seizures associated with epilepsy.

State officials agreed this week to fund $1.6 million of infrastructure upgrades as part of the redevelopment of the former Hewlett Packard complex in Marlborough, according to the Marlborough Economic Development Corporation.

Boston Biomedical Associates (BBA) had just five employees in a single Northborough suite when it launched in 1999. As the biomedical consulting industry grew, BBA expanded its headcount to 52. Those employees worked out of five suites scattered throughout an office building, making it difficult to coordinate across departments, said Mack Rubley, the company's director of business development.

Boston Scientific has completed its acquisition of a division of the Lowell-based electrophysiology business of C.R. Bard, which the Natick-based medical device manufacturer said could significantly boost its capabilities in the fast-growing market for advanced electrophysiology procedures.

The U.S. Food and Drug Administration has asked Marlborough-based Sunovion Pharmaceuticals Inc. to stop distributing promotional brochures for respiratory drug Brovana that it considers deceptive, according to a letter released Tuesday.

UMass Memorial Health Care is bracing for layoffs as well as other cost-cutting measures in the face of a projected $57-million operating loss for its recently completed fiscal year.

A day after it said it would cut up to 1,500 jobs over the next two years, and on the same day it announced a third-quarter loss of $5 million, Boston Scientific said its chief financial officer will leave after the end of the year.

Three of the least safe Bay State hospitals are located in Central Massachusetts, according to a report compiled Wednesday by a nonprofit.

A housing developer paid $14.88 million Monday to buy a 23.5 acre parcel in Marlborough where it plans to build 350 apartments.